{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:45:19Z","timestamp":1785321919126,"version":"3.55.0"},"reference-count":45,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["451-03-136\/2025-03\/200111"],"award-info":[{"award-number":["451-03-136\/2025-03\/200111"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["451-03-137\/2025-03\/200111"],"award-info":[{"award-number":["451-03-137\/2025-03\/200111"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["451-03-136\/2025-03\/200378"],"award-info":[{"award-number":["451-03-136\/2025-03\/200378"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["451-03-136\/2025-03\/200122"],"award-info":[{"award-number":["451-03-136\/2025-03\/200122"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["451-03-136\/2025-03\/200161"],"award-info":[{"award-number":["451-03-136\/2025-03\/200161"]}]},{"name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","award":["451-03-137\/2025-03\/200161"],"award-info":[{"award-number":["451-03-137\/2025-03\/200161"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Lurasidone (LUR) is an antipsychotic drug whose interaction with human serum albumin (HSA) plays a crucial role in its pharmacokinetic and pharmacodynamic properties. A thorough understanding of LUR\u2019s binding mechanism to HSA is crucial for predicting its transport, distribution, and potential drug interactions. Methods: The interaction between LUR and HSA was investigated using fluorescence and circular dichroism (CD) spectroscopy, followed by molecular docking simulations. Binding characteristics were analyzed through quenching mechanisms, thermodynamic parameters, and competitive site marker experiments. Results: This study revealed a systematic decrease in HSA fluorescence intensity with increasing LUR concentration, indicating a static quenching mechanism driven by non-fluorescent complex formation. Binding constants suggest enhanced complex stability at higher temperatures, with thermodynamic analysis confirming an endothermic, hydrophobic interaction. Competitive site marker assays and synchronous fluorescence spectra confirmed that LUR primarily binds to site I (subdomain IIA) near tryptophan residues. Conformational changes in HSA, observed as a decrease in \u03b1-helix content, further demonstrate the structural impact of LUR binding. Conclusions: These findings offer key insights into the molecular interactions between LUR and HSA, enhancing our understanding of LUR\u2019s pharmacokinetics and its potential interactions with other drugs. Understanding these binding characteristics can aid in optimizing LUR\u2019s clinical application and predicting possible interactions with other biomolecules.<\/jats:p>","DOI":"10.3390\/molecules30071420","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T04:48:18Z","timestamp":1742791698000},"page":"1420","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Molecular Recognition of Lurasidone by Human Serum Albumin: A Combined Experimental and Computational Approach"],"prefix":"10.3390","volume":"30","author":[{"given":"Nevena","family":"\u017divkovi\u0107","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovi\u0107a 69, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-2326","authenticated-orcid":false,"given":"Emina","family":"Mrkali\u0107","sequence":"additional","affiliation":[{"name":"Department of Science, Institute for Information Technologies, University of Kragujevac, Jovana Cviji\u0107a bb, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratomir","family":"Jeli\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovi\u0107a 69, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7300-5385","authenticated-orcid":false,"given":"Jovica","family":"Tomovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovi\u0107a 69, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadranka","family":"Odovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina \u0106endi\u0107","family":"Serafinovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovi\u0107a 12, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3300-6199","authenticated-orcid":false,"given":"Miroslav","family":"Sovrli\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovi\u0107a 69, 34000 Kragujevac, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Du, X., Li, Y., Xia, Y.L., Ai, S.M., Liang, J., Sang, P., Ji, X.L., and Liu, S.Q. (2016). Insights into Protein\u2013Ligand Interactions: Mechanisms, Models, and Methods. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17020144"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"116200","DOI":"10.1016\/j.molliq.2021.116200","article-title":"Studying the interaction of drug\/ligand with serum albumin","volume":"336","author":"Siddiqui","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","article-title":"The uniqueness of albumin as a carrier in nanodrug delivery","volume":"18","author":"Spada","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/acsbiomaterials.2c01553","article-title":"Insight on serum albumin: From structure and biological properties to functional biomaterials for bone repair","volume":"9","author":"Jin","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijbiomac.2020.10.152","article-title":"Crystal structure of pharmaceutical-grade human serum albumin","volume":"166","author":"Park","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/mp400027q","article-title":"Subdomain IB is the third major drug binding region of human serum albumin: Toward the three-sites model","volume":"10","author":"Zsila","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Radomska, K., and Wolszczak, M. (2022). Spontaneous and ionizing radiation-induced aggregation of human serum albumin: Dityrosine as a fluorescent probe. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158090"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ayimbila, F., Tantimongcolwat, T., Ruankham, W., Pingaew, R., Prachayasittikul, V., Worachartcheewan, A., Prachayasittikul, V., Prachayasittikul, S., and Phopin, K. (2024). Insight into the binding mechanisms of fluorinated 2-aminothiazole sulfonamide and human serum albumin: Spectroscopic and in silico approaches. Int. J. Biol. Macromol., 277.","DOI":"10.1016\/j.ijbiomac.2024.134048"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/acs.molpharmaceut.9b00772","article-title":"Molecular interactions of drugs","volume":"17","author":"Heng","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.7573\/dic.2022-10-1","article-title":"Lurasidone for the treatment of schizophrenia in adult and paediatric populations","volume":"12","author":"Guilera","year":"2023","journal-title":"Drugs Context."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/14656566.2022.2137403","article-title":"Critical appraisal of lurasidone in the management of schizophrenia","volume":"23","author":"Ceskova","year":"2022","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_12","first-page":"107","article-title":"Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy?","volume":"Volume 1","author":"Ritsner","year":"2013","journal-title":"Polypharmacy in Psychiatry Practice: Multiple Medication Use Strategies"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/NDT.S18059","article-title":"Pharmacokinetics of antipsychotics","volume":"8","author":"Caccia","year":"2012","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s43440-020-00102-5","article-title":"The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions","volume":"72","author":"Danek","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"128805","DOI":"10.1016\/j.molstruc.2020.128805","article-title":"Human and bovine serum albumin time-resolved fluorescence: Tryptophan and tyrosine contributions, effect of DMSO and rotational diffusion","volume":"1221","author":"Starosta","year":"2020","journal-title":"J. Mol. Struct."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1021\/ac1018028","article-title":"Quantitation, visualization, and monitoring of conformational transitions of human serum albumin by a tetraphenylethene derivative with aggregation-induced emission characteristics","volume":"82","author":"Hong","year":"2010","journal-title":"Anal. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/00387010.2010.546470","article-title":"Static and dynamic quenching of tryptophan fluorescence in various proteins by a chromium (III) complex","volume":"44","author":"Crouse","year":"2011","journal-title":"Spectrosc. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/bi00745a021","article-title":"Quenching of protein fluorescence by oxygen. Detection of structural fluctuations in proteins on the nanosecond time scale","volume":"12","author":"Lakowicz","year":"1973","journal-title":"Biochemistry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/ijms15033580","article-title":"Interactive association of drugs binding to human serum albumin","volume":"15","author":"Yang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1039\/C1RA00521A","article-title":"The adsorption of an anticancer hydrazone by protein: An unusual static quenching mechanism","volume":"2","author":"Tian","year":"2012","journal-title":"RSC. Adv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/jf301139h","article-title":"Multispectroscopic and Molecular Modeling Approach to Investigate the Interaction of Flavokawain B with Human Serum Albumin","volume":"60","author":"Feroz","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00706-018-2310-z","article-title":"Interaction of haloperidol with human serum albumin and effect of metal ions on the binding","volume":"149","year":"2018","journal-title":"Monatshefte f\u00fcr Chemie"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"da Silva Fragoso, V.M., de Morais Coura, C.P., Hoppe, L.Y., Soares, M.A.G., Silva, D., and Cortez, C.M. (2016). Binding of sulpiride to seric albumins. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010059"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"120084","DOI":"10.1016\/j.molliq.2022.120084","article-title":"Comparative study of two antipsychotic drugs binding to human serum albumin: By multispectroscopic and molecular docking methods","volume":"365","author":"Huang","year":"2022","journal-title":"J. Mol. Liq."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/1871527316666170303144817","article-title":"Clinically relevant drug interactions with anti-Alzheimer\u2019s drugs","volume":"16","author":"Caraci","year":"2017","journal-title":"CNS Neurol. Disord. Drug. Targets."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5455\/bcp.20140311041445","article-title":"Risk of psychotropic drug interactions in real world settings: A pilot study in patients with schizophrenia and schizoaffective disorder","volume":"24","author":"Sengul","year":"2014","journal-title":"Klin. Psikofarmakol. B."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1021\/bi00514a017","article-title":"Thermodynamics of Protein Association Reactions: Forces Contributing to Stability","volume":"20","author":"Ross","year":"1981","journal-title":"Biochemistry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5483\/BMBRep.2006.39.5.530","article-title":"Conformational study of human serum albumin in pre-denaturation temperatures by differential scanning calorimetry, circular dichroism and UV spectroscopy","volume":"39","author":"Moghaddamnia","year":"2006","journal-title":"BMB Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2174\/0929867023369673","article-title":"Reversible and covalent binding of drugs to human serum albumin: Methodological approaches and physiological relevance","volume":"9","author":"Bertucci","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jlumin.2014.02.009","article-title":"A combined spectroscopic and molecular docking study on site selective binding interaction of Toluidine blue O with Human and Bovine serum albumins","volume":"151","author":"Sharma","year":"2014","journal-title":"J. Lumin."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Abdelhameed, A.S., Alanazi, A.M., Bakheit, A.H., Hassan, E.S., Herqash, R.N., and Almutairi, F.M. (2019). Novel BTK inhibitor acalabrutinib (ACP-196) tightly binds to site I of the human serum albumin as observed by spectroscopic and computational studies. Int. J. Biol. Macromol., 127.","DOI":"10.1016\/j.ijbiomac.2019.01.083"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"116715","DOI":"10.1016\/j.molliq.2021.116715","article-title":"Evaluation of interactions between food colorant, tartrazine, and Apo-transferrin using spectroscopic analysis and docking simulation","volume":"339","author":"Farhadian","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e202303943","DOI":"10.1002\/anie.202303943","article-title":"Macrocyclic \u03b2-Sheets Stabilized by Hydrogen Bond Surrogates","volume":"62","author":"Nazzaro","year":"2023","journal-title":"Angew. Angew. Chem. Int. Ed."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/jacsau.1c00449","article-title":"Accurate machine learning prediction of protein circular dichroism spectra with embedded density descriptors","volume":"1","author":"Zhao","year":"2021","journal-title":"JACS. Au"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkac345","article-title":"BeStSel: Webserver for secondary structure and fold prediction for protein CD spectroscopy","volume":"50","author":"Micsonai","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Am\u00e9zqueta, S., Beltr\u00e1n, J.L., Bolioli, A.M., Campos-Vicens, L., Luque, F.J., and R\u00e0fols, C. (2021). Evaluation of the interactions between human serum albumin (HSA) and non-steroidal anti-inflammatory (NSAIDs) drugs by multiwavelength molecular fluorescence, structural and computational analysis. Pharmaceuticals, 14.","DOI":"10.3390\/ph14030214"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Vesovi\u0107, M., Jeli\u0107, R., Nikoli\u0107, M., Nedeljkovi\u0107, N., \u017divanovi\u0107, A., Bukonji\u0107, A., Mrkali\u0107, E., Radi\u0107, G., Ratkovi\u0107c, Z., and Kljun, J. (2024). Investigation of the interaction between S-isoalkyl derivatives of the thiosalicylic acid and human serum albumin. J. Biomol. Struct. Dyn., 1\u201314.","DOI":"10.1080\/07391102.2024.2301745"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lakowicz, J.R. (2006). Principles of Fluorescence Spectroscopy, Springer. [3rd ed.].","DOI":"10.1007\/978-0-387-46312-4"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Mrkali\u0107, E., Jeli\u0107, R., Stojanovi\u0107, S., and Sovrli\u0107, M. (2021). Interaction between olanzapine and human serum albumin and effect of metal ions, caffeine and flavonoids on the binding: A spectroscopic study. Spectrochim. Acta A Mol. Biomol. Spectrosc., 249.","DOI":"10.1016\/j.saa.2020.119295"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/bio.3414","article-title":"Spectroscopic investigation of the anticancer alkaloid piperlongumine binding to human serum albumin from the viewpoint of drug delivery","volume":"33","author":"Liu","year":"2018","journal-title":"Luminescence"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.saa.2004.05.028","article-title":"Molecular spectroscopic study on the interaction of tetracyclines with serum albumins","volume":"61","author":"Bi","year":"2005","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_43","unstructured":"Dassault Syst\u00e8mes BIOVIA (2016). Discovery Studio, Dassault Syst\u00e8mes. Version 17.2.0."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective re-ceptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_45","first-page":"57","article-title":"Phyton: A programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/7\/1420\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:58:38Z","timestamp":1760029118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/7\/1420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["molecules30071420"],"URL":"https:\/\/doi.org\/10.3390\/molecules30071420","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]}}}